PRKAA2 and neoplasm: Given this propensity to switch off cell growth and proliferation, and the discovery that the principal upstream kinase phosphorylating and activating AMPK was the well-established tumour suppressor LKB1 [14–16], it seemed likely that AMPK would play a beneficial role (Dr Jekyll)!